Sukhtian Ghiath M.

Outlook Therapeutics, Inc. · Director, 10% Owner

Sukhtian Ghiath M. is listed in public filings as director, 10 percent owner:. This Sukhtian Ghiath M. insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Outlook Therapeutics, Inc. (OTLK). Investors use Sukhtian Ghiath M.'s insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.

Latest Actions

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Outlook Therapeutics, Inc.OTLK$08.6M sharesOtherMay 28, 2026$12.0M8.6M shares$1.40--
Outlook Therapeutics, Inc.OTLK$03.5M sharesOtherMay 28, 2026$7.8M3.5M shares$2.26--
Outlook Therapeutics, Inc.OTLK$5.0M8.6M sharesBuyMay 28, 2026$5.0M8.6M shares$0.5855--
Outlook Therapeutics, Inc.OTLK$13M22.1M sharesBuyMay 28, 2026$5.0M8.5M shares$0.5855--
Outlook Therapeutics, Inc.OTLK$2.0M3.5M sharesBuyMay 28, 2026$2.0M3.5M shares$0.5855--

Insider Trades History

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Outlook Therapeutics, Inc.OTLK$12M8.6M sharesGrant / ExerciseMay 27, 2025$12.0M8.6M shares$1.40--
Outlook Therapeutics, Inc.OTLK$19M13.6M sharesGrant / ExerciseMay 27, 2025$6.0M4.3M shares$1.40--
Outlook Therapeutics, Inc.OTLK$03.5M sharesOtherJan 17, 2025$26.6M3.5M shares$7.70--
Outlook Therapeutics, Inc.OTLK$03.5M sharesGrant / ExerciseJan 17, 2025$8.7M3.5M shares$2.51--
Outlook Therapeutics, Inc.OTLK$8.7M3.5M sharesGrant / ExerciseJan 17, 2025$8.7M3.5M shares$2.51--
Outlook Therapeutics, Inc.OTLK$23M9.3M sharesGrant / ExerciseJan 17, 2025$8.7M3.5M shares$2.51--
Outlook Therapeutics, Inc.OTLK$7.8M3.5M sharesGrant / ExerciseJan 17, 2025$7.8M3.5M shares$2.26--